Skip to content
Trouver

Medicine in DR Congo · official US FDA label

Polyvidone iodé 10% 10%

Povidone iodée (povidone) · solution

Authorized in DR Congo

Want to buy it?

Not in stock in our pharmacies right now. Trouver shows when it is back near you. The reservation pages are in French.

See the pharmacies

This is a US label.

The official US FDA label for povidone (published as POVIDONE IODINE 10%), effective August 26, 2026, describes products sold in the United States. The medicine sold in DR Congo may differ in strength, form or approved uses: ask a pharmacist or a doctor.

Official US FDA label for povidone

Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. The full label on DailyMed.

Uses

Uses Health care antiseptic for preparation of the skin prior to surgery. First Aid antiseptic to help prevent the risk of skin infection in minor cuts, scrapes and burns.

Dosage

US dosage, for products sold in the United States. For a medicine bought in DR Congo, follow its box, its leaflet or your pharmacist.

Directions For preparation of the skin prior to surgery Clean the affected area Remove swab by stick Apply to the operative site prior to surgery For use as a first aid antiseptic Clean the affected area apply a small amount of this product (equal to the surface area of a fingertip) to the area 1 to 3 times daily. may be covered with a sterile bandage if bandaged let dry first

Warnings and precautions

Warnings For external Use Only Do not use in eyes over large areas of the body on individuals who are allergic or sensitive to iodine as a first aid antiseptic longer than 1 week unless directed by a doctor

Where to find it in DR Congo

Not in stock in our pharmacies right now

Stock changes with every sale. Search by substance: a medicine with the same composition may be available.

Composition

SubstanceStrengthATC code
Povidone iodée (povidone)10%—

Marketing authorization in DR Congo

From the register of the ACOREP (the Congolese pharmaceutical regulatory authority).

  • Authorization number

    ACRP/CAB/DG/D11/00/C/MH/2244/2025

    Valid from April 24, 2025 until April 24, 2030

    Holder
    Laboratoire Phatkin N° 66-77 – Av. Kabalo C/Kinshasa/R.D.C.
    Manufacturer
    Laboratoire Phatkin N° 66-77 – Av. Kabalo C/Kinshasa/R.D.C
    Country
    Congo (la République démocratique du)

Sources

  • ●Labels: U.S. Food and Drug Administration, openFDA (public domain). Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. DailyMed.
  • ●English names of substances: RxNorm, U.S. National Library of Medicine.
  • ●Marketing authorizations: register of the ACOREP, DR Congo, version of February 4, 2026.

Public information, for reference only: it does not replace the advice of a pharmacist or a doctor. Vimpia writes nothing about how to use a medicine and translates nothing: the label is the US FDA's, unchanged; names, composition and authorizations come from the official sources above.